C.D.C. Complete tandzorg has sold a stake to G Square Healthcare Pte. Equity

G Square Healthcare Private Equity (G Square) has invested in C.D.C. Complete tandzorg (CDC). The partnership will enable CDC to expand its complex dental care service offering to other regions in the Netherlands by opening new practices. Financial details have not been made public.

CDC has become Netherlands’ leading dental care provider for patients who need complex treatments. CDC is specialized in the construction, placement and maintenance of dental prosthesis such as bridges and crowns, dentures, click dentures and dental implants. In addition, CDC assists patients in finding the optimal dental care solution within their insurance coverage and budget and has a special dental program for children.

G Square is a London-based, independent private equity firm, targeting mid-sized healthcare companies in Europe. G Square Capital I is the first private equity fund managed by G Square and CDC is the sixth investment.

Dr. Laurent Ganem, President and founder of G Square, said: “We are delighted to invest in CDC and look forward to working together with its highly knowledgeable and experienced management. The anesthetic center and patient-oriented approach made CDC become a thriving dental care provider with a unique market position. We are very impressed with what has been achieved so far and believe that management has the capability to successfully replicate the model to other locations in the Netherlands.”

Eric and Rob Dral, founders and managers of CDC, said: “The pan-European healthcare and especially dental care experience of G Square is very attractive for us. We believe G Square is the perfect partner and will be able to support us in our growth objectives. Holland Corporate Finance and the UK-based Cavendish Corporate Finance, played a fundamental role in identifying G Square as a buyer and realizing the transaction in a dedicated and professional manner."

Oaklins' team in the Netherlands, together with Oaklins Cavendish, based in the UK, advised the shareholders of CDC in this transaction. This deal is another example of the seamless cooperation between Oaklins' teams, demonstrating the organization’s added value through its global execution capabilities, industry expertise and contacts.